Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress
Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress
复制标题
DOI:
10.1001/jama.290.19.2564
复制
发表时间:
2003-11-19
影响因子:
120.7
通讯作者:
Levy, HL
中科院分区:
文献类型:
--
作者:
Waisbren, SE;Albers, S;Levy, HL
Context Tandem mass spectrometry now allows newborn screening for more than 20 biochemical genetic disorders. Questions about the effectiveness and risks of expanded newborn screening for biochemical genetic disorders need to be answered prior to its widespread acceptance as a state-mandated program.Objectives To compare newborn identification by expanded screening with clinical identification of biochemical genetic disorders and to assess the impact on families of a false-positive screening result compared with a normal result in the expanded newborn screening program.Design Prospective study involving an inception cohort of newly diagnosed children.Setting Massachusetts, Maine, and a private laboratory in Pennsylvania with expanded newborn screening; other New England states with limited screening.Participants Families of 50 affected children identified through expanded newborn screening (82% of eligible cases); 33 affected children identified clinically (97% of eligible cases); 94 screened children with false-positive results (75% of eligible cases); and 81 screened children with normal results (63% of eligible cases).Main Outcome Measures Child's health and development and the Parental Stress Index.Results Within the first 6 months of life, 28% of children identified by newborn screening compared with 55% of clinically identified children required hospitalization (P=.02). One child identified by newborn screening compared with 8 (42%) identified clinically performed in the range of mental retardation (P